Inventor · disambiguated record
Hitesh Sanganee
Also filed as: SANGANEE HITESH · SANGANEE HITESH JAYANTILAL
19 granted patents·11 pending applications·189 citations·filing 1994–2021
94Inventor score
Top patents by PatentIndex Score
30 records- 0191US7179922B2Chemical compoundsASTRAZENECA AB·Filed 2005·Granted Feb 20, 2007·16 cites·18 claims
- 0291US6903115B2Bipiperidine compoundsASTRAZENECA AB·Filed 2003·Granted Jun 7, 2005·35 cites·13 claims
- 0390US6525070B2Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonistsASTRAZENECA AB·Filed 2001·Granted Feb 25, 2003·33 cites·13 claims
- 0489US7902181B2Compounds 010ASTRAZENECA AB·Filed 2008·Granted Mar 8, 2011·20 cites·13 claims
- 0585US7238811B2Chemical compoundsASTRAZENECA AB·Filed 2003·Granted Jul 3, 2007·16 cites·5 claims
- 0683US7166607B2Substituted indolesASTRAZENECA AB·Filed 2003·Granted Jan 23, 2007·26 cites·7 claims
- 0780US7238691B2Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activityASTRAZENECA AB·Filed 2002·Granted Jul 3, 2007·14 cites·10 claims
- 0874US7723373B2Indole-3-sulphur derivativesASTRAZENECA AB·Filed 2003·Granted May 25, 2010·8 cites·17 claims
- 0973US11246870B2MPO inhibitors for use in medicineASTRAZENECA AB·Filed 2018·Granted Feb 15, 2022·1 cites·13 claims
- 1073US7754735B2Substituted indolesASTRAZENECA AB·Filed 2003·Granted Jul 13, 2010·8 cites·12 claims
- 1172US7517989B2Piperidine derivatives useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2003·Granted Apr 14, 2009·5 cites·6 claims
- 1270US11738027B2MPO inhibitors for use in medicineASTRAZENECA AB·Filed 2021·Granted Aug 29, 2023·0 cites·13 claims
- 1370US8198285B2Pyrazine derivativesFENG TAO·Filed 2011·Granted Jun 12, 2012·1 cites·6 claims
- 1469US7348341B2Chemical compoundsASTRAZENECA AB·Filed 2001·Granted Mar 25, 2008·4 cites·16 claims
- 1560US2007179297A1Chemical compoundsASTRAZENECA AB A SWEDEN CORP·Filed 2007·Application pending·0 cites
- 1659US2010204203A1Chemical Compounds 637: Pyridopyrimidinediones as PDE4 InhibitorsBONNERT ROGER VICTOR·Filed 2008·Application pending·0 cites
- 1759US2009124596A1Chemical Compounds 637BONNERT ROGER VICTOR·Filed 2008·Application pending·0 cites
- 1858US2009069325A1Piperidine Derivatives Useful as Modulators of Chemokine Receptor ActivityASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1950US2012077801A1Chemical Compounds 637BONNERT ROGER VICTOR·Filed 2011·Application pending·0 cites
- 2048US2008207650A1Chemical Compounds 636BONNERT ROGER VICTOR·Filed 2008·Application pending·0 cites
- 2148US2013123275A1Pyrazine derivativesFENG TAO·Filed 2012·Application pending·0 cites
- 2243US7482363B2Piperidine derivatives useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2003·Granted Jan 27, 2009·0 cites·7 claims
- 2343US2009233907A1Pyridopyrimidine Derivatives and Their Use as PDE4 InhibitorsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2441US5801249AChiral auxiliariesOXFORD ASYMMETRY INTERNATIONAL·Filed 1994·Granted Sep 1, 1998·2 cites·10 claims
- 2541US2011201581A1Novel Compounds 010FURBER MARK·Filed 2011·Application pending·0 cites
- 2640US8273774B2Phenoxypyridinylamide compoundsANDREWS GLEN·Filed 2009·Granted Sep 25, 2012·0 cites·20 claims
- 2740US7304077B2Chemical compoundsASTRAZENECA AB·Filed 2001·Granted Dec 4, 2007·0 cites·9 claims
- 2836US8093278B2Substituted indolesBIRKINSHAW TIMOTHY·Filed 2010·Granted Jan 10, 2012·0 cites·12 claims
- 2935US2010197756A1Indole-3-Sulphur DerivativesBONNERT ROGER·Filed 2010·Application pending·0 cites
- 3032US2016089089A1Systems and methods for digital predictive disease exacerbation and pre-emptive treatmentAEDIO INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →